• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Five Prime Therapeutics Inc

+ Add to Watchlist

FPRX:US

14.1100 USD 0.1900 1.36%

As of 20:10:00 ET on 07/22/2014.

Snapshot for Five Prime Therapeutics Inc (FPRX)

Open: 14.0200 Day's Range: 13.8700 - 14.5000 Volume: 78,643
Previous Close: 13.9200 52wk Range: 8.0200 - 23.3300 1-Yr Rtn: -

Stock Chart for FPRX

No chart data available.
  • FPRX:US 14.0900
  • 1D
  • 1M
  • 1Y
13.9200
Interactive FPRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FPRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.4320
Est. PEG Ratio -
Market Cap (M USD) 302.50
Shares Outstanding (M) 21.44
30 Day Average Volume 224,889
Price/Book (mrq) 4.0954
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FPRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FPRX

Five Prime Therapeutics, Inc. provides clinical stage biotech services. The Company discovers and develops a complete range of innovative protein and antibody therapeutics, as well as offers drugs for oncology and immunology diseases. FivePrime conducts business throughout the United States and Canada.

Lewis T Williams "Rusty"President/CEO/Co-FounderMarc L BelskySenior VP/CFO
Julie HambletonSenior VP/Chief Medical OfcrAron M KnickerbockerSenior VP/Chief Business Ofcr
More Company Profile & Key Executives for FPRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil